MELISSA SMITH: Open Payments
NPI 1053393066 · RIVERVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$623 in 28 payments from 15 companies in 2025. Trend: 2023 $2,862 · 2024 $2,593 · 2025 $623
Food & beverage: $524Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $158 |
| AstraZeneca Pharmaceuticals LP | 5 | $80 |
| Lilly USA, LLC | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $51 |
| PFIZER INC. | 2 | $41 |
| Novo Nordisk Inc | 2 | $39 |
| Amgen Inc. | 2 | $32 |
| ABBVIE INC. | 2 | $28 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Insmed, Inc. | 1 | $23 |
Products named: Veozah, Kerendia, AIRSUPRA, MOUNJARO, VRAYLAR, CAPVAXIVE, JARDIANCE, Arikayce.
Industry payments across FL — which companies pay providers there.
